ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923 This issue Cite
Erratum
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou, 510060, China
Citation:
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
Other stylesCorrected-article in Theranostics, Volume 7, 1447
Citation styles
APA
Zhou, J., Jin, B., Jin, Y., Liu, Y., Pan, J. (2020). The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics, 10(16), 7401-7402. https://doi.org/10.7150/thno.47923.
ACS
Zhou, J.; Jin, B.; Jin, Y.; Liu, Y.; Pan, J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020, 10 (16), 7401-7402. DOI: 10.7150/thno.47923.
NLM
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
CSE
Zhou J, Jin B, Jin Y, Liu Y, Pan J. 2020. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics. 10(16):7401-7402.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.